A new National Institutes of Health (NIH) program aims to speed the clinical translation of gene-editing technologies like clustered regularly interspaced short palindromic repeats–Cas9 (CRISPR-Cas9).
The Somatic Cell Genome Editing program will award $190 million to researchers over 6 years. Participating scientists will work together to develop new ways to deliver gene-editing tools, create better gene editors, and design ways to test the safety and efficacy of clinical gene editing. They will also develop a toolkit that can be broadly shared.
Kuehn B. Accelerating Clinical Gene Editing. JAMA. 2018;319(8):760. doi:10.1001/jama.2018.1292
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: